Literature DB >> 33398161

Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.

Ruiping Wang1, Minghao Dang1, Kazuto Harada2,3, Guangchun Han1, Fang Wang4, Melissa Pool Pizzi2, Meina Zhao2, Ghia Tatlonghari2, Shaojun Zhang1, Dapeng Hao1, Yang Lu5, Shuangtao Zhao1, Brian D Badgwell6, Mariela Blum Murphy2, Namita Shanbhag2, Jeannelyn S Estrella7, Sinchita Roy-Chowdhuri7, Ahmed Adel Fouad Abdelhakeem2, Yuanxin Wang1, Guang Peng8, Samir Hanash8, George A Calin9, Xingzhi Song1, Yanshuo Chu1, Jianhua Zhang1, Mingyao Li10, Ken Chen4, Alexander J Lazar7,11, Andrew Futreal1, Shumei Song2, Jaffer A Ajani12, Linghua Wang13,14.   

Abstract

Intratumoral heterogeneity (ITH) is a fundamental property of cancer; however, the origins of ITH remain poorly understood. We performed single-cell transcriptome profiling of peritoneal carcinomatosis (PC) from 15 patients with gastric adenocarcinoma (GAC), constructed a map of 45,048 PC cells, profiled the transcriptome states of tumor cell populations, incisively explored ITH of malignant PC cells and identified significant correlates with patient survival. The links between tumor cell lineage/state compositions and ITH were illustrated at transcriptomic, genotypic, molecular and phenotypic levels. We uncovered the diversity in tumor cell lineage/state compositions in PC specimens and defined it as a key contributor to ITH. Single-cell analysis of ITH classified PC specimens into two subtypes that were prognostically independent of clinical variables, and a 12-gene prognostic signature was derived and validated in multiple large-scale GAC cohorts. The prognostic signature appears fundamental to GAC carcinogenesis and progression and could be practical for patient stratification.

Entities:  

Mesh:

Year:  2021        PMID: 33398161      PMCID: PMC8074162          DOI: 10.1038/s41591-020-1125-8

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  68 in total

1.  Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

Authors:  Naruhiko Ikoma; Prajnan Das; Wayne Hofstetter; Jaffer A Ajani; Jeannelyn S Estrella; Hsiang-Chun Chen; Xuemei Wang; Rashida A Callender; Cong Zhu; Christina L Roland; Keith F Fournier; Janice N Cormier; Paul Mansfield; Brian D Badgwell
Journal:  Gastric Cancer       Date:  2018-05-05       Impact factor: 7.370

Review 2.  Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Authors:  Julien Taieb; Markus Moehler; Narikazu Boku; Jaffer A Ajani; Eduardo Yañez Ruiz; Min-Hee Ryu; Silke Guenther; Vikram Chand; Yung-Jue Bang
Journal:  Cancer Treat Rev       Date:  2018-04-22       Impact factor: 12.111

3.  Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.

Authors:  Dilsa Mizrak Kaya; Graciela M Nogueras-González; Kazuto Harada; Fatemeh G Amlashi; Sinchita Roy-Chowdhuri; Jeannelyn S Estrella; Prajnan Das; Jeffrey H Lee; Brian Weston; Manoop S Bhutani; Aurelio Matamoros; Irene Thomas; Quan Lin; Brian D Badgwell; Jaffer A Ajani
Journal:  J Surg Oncol       Date:  2017-12-04       Impact factor: 3.454

4.  HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.

Authors:  Angela N Bartley; Mary Kay Washington; Carol Colasacco; Christina B Ventura; Nofisat Ismaila; Al B Benson; Alfredo Carrato; Margaret L Gulley; Dhanpat Jain; Sanjay Kakar; Helen J Mackay; Catherine Streutker; Laura Tang; Megan Troxell; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2016-11-14       Impact factor: 44.544

5.  Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis.

Authors:  Cong Chen; Fan Zhang; Ning Zhou; Yan-Mei Gu; Ya-Ting Zhang; Yi-Di He; Ling Wang; Lu-Xi Yang; Yang Zhao; Yu-Min Li
Journal:  Oncoimmunology       Date:  2019-03-05       Impact factor: 8.110

6.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.

Authors:  Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; Marc H Wadsworth; Daniel Treacy; John J Trombetta; Asaf Rotem; Christopher Rodman; Christine Lian; George Murphy; Mohammad Fallahi-Sichani; Ken Dutton-Regester; Jia-Ren Lin; Ofir Cohen; Parin Shah; Diana Lu; Alex S Genshaft; Travis K Hughes; Carly G K Ziegler; Samuel W Kazer; Aleth Gaillard; Kellie E Kolb; Alexandra-Chloé Villani; Cory M Johannessen; Aleksandr Y Andreev; Eliezer M Van Allen; Monica Bertagnolli; Peter K Sorger; Ryan J Sullivan; Keith T Flaherty; Dennie T Frederick; Judit Jané-Valbuena; Charles H Yoon; Orit Rozenblatt-Rosen; Alex K Shalek; Aviv Regev; Levi A Garraway
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

7.  Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.

Authors:  Hironori Shiozaki; Elena Elimova; Rebecca S Slack; Hsiang-Chun Chen; Gregg A Staerkel; Nour Sneige; Yusuke Shimodaira; Tara Sagebiel; Jeffrey H Lee; Manoop S Bhutani; Prajnan Das; Paul F Mansfield; Jeannelyn S Estrella; Brian D Badgwell; Jaffer A Ajani
Journal:  J Surg Oncol       Date:  2015-11-25       Impact factor: 3.454

8.  Construction of a human cell landscape at single-cell level.

Authors:  Xiaoping Han; Ziming Zhou; Lijiang Fei; Huiyu Sun; Renying Wang; Yao Chen; Haide Chen; Jingjing Wang; Huanna Tang; Wenhao Ge; Yincong Zhou; Fang Ye; Mengmeng Jiang; Junqing Wu; Yanyu Xiao; Xiaoning Jia; Tingyue Zhang; Xiaojie Ma; Qi Zhang; Xueli Bai; Shujing Lai; Chengxuan Yu; Lijun Zhu; Rui Lin; Yuchi Gao; Min Wang; Yiqing Wu; Jianming Zhang; Renya Zhan; Saiyong Zhu; Hailan Hu; Changchun Wang; Ming Chen; He Huang; Tingbo Liang; Jianghua Chen; Weilin Wang; Dan Zhang; Guoji Guo
Journal:  Nature       Date:  2020-03-25       Impact factor: 49.962

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

Authors:  Ruiping Wang; Shumei Song; Kazuto Harada; Fatemeh Ghazanfari Amlashi; Brian Badgwell; Melissa Pool Pizzi; Yan Xu; Wei Zhao; Xiaochuan Dong; Jiangkang Jin; Ying Wang; Ailing Scott; Lang Ma; Longfei Huo; Diego Vicente; Mariela Blum Murphy; Namita Shanbhag; Ghia Tatlonghari; Irene Thomas; Jane Rogers; Makoto Kobayashi; Jody Vykoukal; Jeannelyn Santiano Estrella; Sinchita Roy-Chowdhuri; Guangchun Han; Shaojun Zhang; Xizeng Mao; Xingzhi Song; Jianhua Zhang; Jian Gu; Randy L Johnson; George Adrian Calin; Guang Peng; Ju-Seog Lee; Samir M Hanash; Andrew Futreal; Zhenning Wang; Linghua Wang; Jaffer A Ajani
Journal:  Gut       Date:  2019-06-06       Impact factor: 23.059

View more
  36 in total

1.  Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities.

Authors:  Yosuke Tanaka; Fumiko Chiwaki; Shinya Kojima; Masahito Kawazu; Masayuki Komatsu; Toshihide Ueno; Satoshi Inoue; Shigeki Sekine; Keisuke Matsusaki; Hiromichi Matsushita; Narikazu Boku; Yae Kanai; Yasushi Yatabe; Hiroki Sasaki; Hiroyuki Mano
Journal:  Nat Cancer       Date:  2021-08-16

Review 2.  Application and prospects of single cell sequencing in tumors.

Authors:  Ruo Han Huang; Le Xin Wang; Jing He; Wen Gao
Journal:  Biomark Res       Date:  2021-12-11

3.  Apatinib plus S-1 for previously treated, advanced gastric or gastro-oesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study.

Authors:  Chao Jing; Zhigang Bai; Jun Zhang; Hongpeng Jiang; Xiaobao Yang; Shu Yan; Jie Yin; Jun Cai; Zhongtao Zhang; Wei Deng
Journal:  J Gastrointest Oncol       Date:  2021-10

4.  Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts.

Authors:  Yoon Young Choi; Eunji Jang; Hyunki Kim; Kyoung-Mee Kim; Sung Hoon Noh; Tae Sung Sohn; Yong-Min Huh; Ji Yeong An; Jae-Ho Cheong
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 5.087

Review 5.  Mapping the genomic diaspora of gastric cancer.

Authors:  Khay Guan Yeoh; Patrick Tan
Journal:  Nat Rev Cancer       Date:  2021-10-26       Impact factor: 60.716

Review 6.  Untangling the web of intratumour heterogeneity.

Authors:  Zheqi Li; Marco Seehawer; Kornelia Polyak
Journal:  Nat Cell Biol       Date:  2022-08-08       Impact factor: 28.213

Review 7.  Applications and Achievements of Single-Cell Sequencing in Gastrointestinal Cancer.

Authors:  Zhenliang Xie; Jincheng Li; Pu Huang; Ye Zhang; Jingkuan Yang; Kangdong Liu; Yanan Jiang
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

8.  Prognostic Significance of Lineage Diversity in Bladder Cancer Revealed by Single-Cell Sequencing.

Authors:  Lu Yu; Rixin Hu; Guoyu Peng; Qiuxia Ding; Tao Tao; Song Wu
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

9.  Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis.

Authors:  Zijian Kang; Jing Wang; Wending Huang; Jianmin Liu; Wangjun Yan
Journal:  Front Cell Dev Biol       Date:  2022-05-13

10.  Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets.

Authors:  Kai Chen; Xinxin Liu; Weikang Liu; Feng Wang; Xiaodong Tian; Yinmo Yang
Journal:  Hum Mol Genet       Date:  2022-05-19       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.